Cargando…

Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation

Solute carrier family 25 member 20 (SLC25A20) is a mitochondrial-membrane–carrier protein involved in the transport of acylcarnitines into mitochondrial matrix for oxidation. A previous-integrated-proteogenomic study had identified SLC25A20 as one of the top-three prognostic biomarkers in HCC. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Peng, Mu, Jiao, Wang, Zijun, Ma, Shuaijun, Da, Xiuwei, Song, Jian, Zhang, Hongxin, Yang, Le, Li, Jibin, Yang, Jingyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024385/ https://www.ncbi.nlm.nih.gov/pubmed/33824298 http://dx.doi.org/10.1038/s41419-021-03648-1

Ejemplares similares

Down-regulation of BMAL1 by MiR-494-3p Promotes Hepatocellular Carcinoma Growth and Metastasis by Increasing GPAM-mediated Lipid Biosynthesis
por: Yang, Yi, et al.
Publicado: (2022)

SLC25A22 as a Key Mitochondrial Transporter Against Ferroptosis by Producing Glutathione and Monounsaturated Fatty Acids
por: Liu, Yang, et al.
Publicado: (2023)

NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A
por: Yuan, Peng, et al.
Publicado: (2017)

Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1
por: Wu, Dan, et al.
Publicado: (2022)

Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
por: Lee, Jae-Seon, et al.
Publicado: (2019)

A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
por: Chen, Haiyang, et al.
Publicado: (2015)

Deficiency of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis
por: Alkan, H. Furkan, et al.
Publicado: (2020)

SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma
por: Fan, Zhongyi, et al.
Publicado: (2022)

SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism
por: Wang, Yong, et al.
Publicado: (2021)

GRK2 Suppresses Hepatocellular Carcinoma Metastasis and Invasion Through Down-Regulation of Prostaglandin E Receptor 2
por: Li, Nan, et al.
Publicado: (2020)

Slc25a39 and Slc25a40 Expression in Mice with Bile Duct Ligation or Lipopolysaccharide Treatment
por: Kawase, Atsushi, et al.
Publicado: (2022)

SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway
por: Chen, Ming-Wei, et al.
Publicado: (2018)

SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer
por: Du, Pengcheng, et al.
Publicado: (2019)

SLC34A2 Up-regulation And SLC4A4 Down-regulation Correlates With Invasion, Metastasis, And The MAPK Signaling Pathway In Papillary Thyroid Carcinomas
por: Huang, Fengyan, et al.
Publicado: (2021)

CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways
por: Wang, Yunwu, et al.
Publicado: (2018)

Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma
por: Fu, Xiao, et al.
Publicado: (2021)

Up-regulation of SLC27A2 suppresses the proliferation and invasion of renal cancer by down-regulating CDK3-mediated EMT
por: Xu, Ning, et al.
Publicado: (2022)

MicroRNA-20a Suppresses Tumor Proliferation and Metastasis in Hepatocellular Carcinoma by Directly Targeting EZH1
por: Zhang, Qianqian, et al.
Publicado: (2021)

Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs
por: Parker, Christopher G., et al.
Publicado: (2017)

One potential hotspot SLC25A20 gene variants in Chinese patients with carnitine-acylcarnitine translocase deficiency
por: Li, Xiaoli, et al.
Publicado: (2022)

SLC25A51 is a mammalian mitochondrial NAD(+) transporter
por: Luongo, Timothy S., et al.
Publicado: (2020)

SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020)

The SLC25 Mitochondrial Carrier Family: Structure and Mechanism
por: Ruprecht, Jonathan J., et al.
Publicado: (2020)

Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver
por: González-Moreno, Luis, et al.
Publicado: (2023)

A novel homozygous missense SLC25A20 mutation in three CACT-deficient patients: clinical and autopsy data
por: Chinen, Yasutsugu, et al.
Publicado: (2020)

In Silico Analysis of the Structural Dynamics and Substrate Recognition Determinants of the Human Mitochondrial Carnitine/Acylcarnitine SLC25A20 Transporter
por: Pasquadibisceglie, Andrea, et al.
Publicado: (2023)

Carnitine-acylcarnitine translocase deficiency caused by SLC25A20 gene heterozygous variants in twins: a case report
por: Zhang, Liya, et al.
Publicado: (2023)

An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis
por: Chen, Yan-Jie, et al.
Publicado: (2022)

Kearns-Sayre syndrome with rare imaging finding of SLC25A4 Mutation
por: Zhao, Huan, et al.
Publicado: (2022)

Slc20a1/Pit1 and Slc20a2/Pit2 are essential for normal skeletal myofiber function and survival
por: Chande, Sampada, et al.
Publicado: (2020)

LncRNA HOXD-AS1 promotes the metastasis of human hepatocellular carcinoma via modulating miR-326/SLC27A4
por: Ji, Wenbin, et al.
Publicado: (2020)

The Mitochondrial Carnitine Acyl-carnitine Carrier (SLC25A20): Molecular Mechanisms of Transport, Role in Redox Sensing and Interaction with Drugs
por: Tonazzi, Annamaria, et al.
Publicado: (2021)

The Mycotoxin Patulin Inhibits the Mitochondrial Carnitine/Acylcarnitine Carrier (SLC25A20) by Interaction with Cys136 Implications for Human Health
por: Giangregorio, Nicola, et al.
Publicado: (2023)

The SLC25A1-p53 mutant crosstalk
por: Albanese, Chris, et al.
Publicado: (2015)

Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy
por: Rochette, Luc, et al.
Publicado: (2020)

MicroRNA-20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression
por: ZHUO, WENKUN, et al.
Publicado: (2015)

Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
por: Kim, Seok Bae
Publicado: (2021)

TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma
por: Sang, Yi, et al.
Publicado: (2015)

Integrin α9 Suppresses Hepatocellular Carcinoma Metastasis by Rho GTPase Signaling
por: Zhang, Yan-Li, et al.
Publicado: (2018)

Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP
por: Li, Minjing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rhkfn4amdbvvb280rlf1kgptqg